Biosensors

Biosensors: strong run up post lunch on higher volumes. We recap the company's announcement this morning that came in just before the opening bell. Majority shareholder Shandong Weigao has agreed to dispose its entire 21.7% stake in Biosensors to CB Medical Holdings for US$312.3m. This transaction values Biosensors at $1.05 per share, a premium of 12% to its last closing price.